Effect of an antioxidant, ebselen, on development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates

Surgical Neurology

Volumn 53, Issue 4, 2000, Pages 323-329

  Handa, Yuji ^a   Kaneko, Masanori ^a   Takeuchi, Hiroaki ^a   Tsuchida, Akira ^a   Kobayashi, Hidenori ^a   Kubota, Toshihiko ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Cerebral vasospasm; Ebselen; Primate; Subarachnoid hemorrhage

Indexed keywords

ANTIOXIDANT; EBSELEN; FREE RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN VASOSPASM; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; LIPID PEROXIDATION; MONKEY; NONHUMAN; SUBARACHNOID HEMORRHAGE;

ANIMALS; ANTIOXIDANTS; AZOLES; CEREBRAL ANGIOGRAPHY; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MACACA FASCICULARIS; ORGANOSELENIUM COMPOUNDS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 0034022112     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(00)00168-3     Document Type: Article

References (38)

1. Chyatte D. Anti-inflammatory agents and cerebral vasospasm. Neurosurg Clin North Am. 1:1990;433-450.
2. Crompton M.R. The pathogenesis of cerebral infarction following the rupture of cerebral artery aneurysm. Brain. 87:1964;491-510.
3. Dawson D.A., Masayasu H., Graham D.I., Macrae I.M. The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischemia in the rat. Neurosci Lett. 185:1995;65-69.
4. Desai I.D., Tappel A.L. Damage to proteins by peroxidized lipids. J Lipid Research. 4:1973;204-207.
5. Fisher C.M., Kistler J.P., Davis J.M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 6:1980;1-9.
6. Gutterridge J.M.C. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. 201:1986;291-295.
7. Haley E.C. Jr, Kassell N.F., Alves W.M., Weir B.K., Hansen C.A. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage a report of the Cooperative Aneurysmal Study . J Neurosurg. 82:1995;786-790.
8. Haley E.C. Jr, Kassell N.F., Apperson-Hansen C., Maile M.H., Alves W.M. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America . J Neurosurg. 86:1997;467-474.
9. Handa Y., Hayashi M., Takeuchi H., Kubota T., Kobayashi H., Kawano H. Time course of cerebral autoregulation during chronic cerebral vasospasm after subarachnoid hemorrhage in primates. J Neurosurg. 76:1992;493-501.
10. Handa Y., Kaneko M., Matuda T., Kobayashi H., Kubota T. In vivo proton magnetic resonance spectroscopy for metabolic changes in brain during chronic cerebral vasospasm in primates. Neurosurgery. 40:1997;773-781.
11. Handa Y., Kaneko M., Tsuchida A., Kobayashi H., Kawano H., Kubota T. Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats. Acta Neurochir. 132:1995;92-97.
12. Handa Y., Kubota T., Tsuchida T., Kaneko M., Caner H., Kobayashi H., Kubota T. Effect of systemic hypotension on cerebral energy metabolism during chronic cerebral vasospasm in primates. J Neurosurg. 78:1993;112-119.
13. Handa Y., Weir B.K.A., Nosko M., Mosewich R., Tsuji T., Grace M. The effect of timing of clot removal on chronic vasospasm in a primate model. J Neurosurg. 67:1987;558-564.
14. Harada T., Mayberg M.R. Inhibition of delayed arterial narrowing by the iron-chelating agent deferoxamine. J Neurosurg. 77:1992;763-767.
15. Hayashi M., Slater T.F. Inhibitory effects of Ebselen on lipid peroxidation in rat liver microsomes. Free Rad Res Comm. 2:1986;179-185.
16. Hughes J.T., Schianchi P.M. Cerebral arterial spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg. 48:1978;515-525.
17. Jhoshita H., Sasaki T., Matsui T., Hanamura T., Masayasu H., Asano T., Takakura K. Effects of ebselen (PZ 51) on ischaemic brain oedema after focal ischaemia in cats. Acta Neurochir. 51:1990;239-241.
18. Kassell N.F., Haley E.C. Jr, Apperson-Hansen C., Alves W.M. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in Europe, Australia, New Zealand . J Neurosurg. 84:1996;221-228.
19. Kellogg E.W., Fridovich I. Superoxide, hydrogen peroxide and singlet oxygen in lipid peroxidation by a xanthin oxidase system. J Biol Chem. 250:1975;8812-8817.
20. Macdonald R.L., Weir B.K.A. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 22:1991;971-982.
21. Macdonald R.L., Weir B.K.A., Grace M.G.A., Chen M.H., Martin T.P., Young J.D. Mechanism of cerebral vasospasm following subarachnoid hemorrhage in monkeys. Can J Neurol Sci. 19:1992;419-427.
22. Macdonald R.L., Weir B.K.A., Runzer T.D., Grace M.G.A., Poznansky M.J. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys. Neurosurgery. 30:1992;529-539.
23. Marzatico F., Gaetani P., Rodriguez Y., Baena R. Experimental subarachnoid hemorrhage:lipid peroxidation and NA+-K+ ATPase in different rat brain areas. Mol Chem Neuropathol. 11:1989;99-107.
24. Mirsa H.P., Fridovich I. The generation of superoxide radicals during autoxidation of hemoglobin. J Bio Chem. 247:1972;6960-6962.
25. Müller A., Cadenas E., Graf P., Sies H. A novel biologically active seleno-organic compound-I, glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochem Pharmacol. 33:1984;3235-3239.
26. Safayhi H, Tiegs G, Wendel A. A novel biologically active seleno-organic compound-V. Inhibition by Ebselen (PZ 51) of rat peritoneal neutrophil lipooxygenase. Biochem Pharmacol 1985;34:2691-4.
27. Saito I., Asano T., Sano K., Takakura K., Abe H., Yoshimoto T., Kikuchi H., Ohta T., Ishibashi S. Neuroprotective effect of an antioxidant, Ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery. 42:1998;269-278.
28. Sano K., Asano T., Tanishima T., Sasaki T. Lipid peroxidation as a cause of cerebral vasospasm. Neurol Res. 2:1980;253-272.
29. Sasaki S., Kuwabara H., Ohta S. Biological defense mechanisms in the pathogenesis of prolonged cerebral vasospasm in patients with ruptured intracranial aneurysm. Stroke. 17:1986;196-202.
30. Sasaki T., Wakai S., Asano T., Watanabe T., Kirino T., Sano K. The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J Neurosurg. 54:1981;357-365.
31. Steinke D.E., Weir B.K.A., Findlay J.M., Tanabe T., Grace M., Krushelnycky B.W. A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery. 24:1989;179-186.
32. Tappel A.L. Lipid peroxidation damage to cell components. Fed Proc. 32:1973;1870-1874.
33. Vollmer D.G., Hongo K., Ogawa H., Tsukahara T., Kassell N.F. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery. 28:1991;27-32.
34. Vollmer D.G., Kassell N.F., Hongo K., Ogawa H., Tsukahara T. Effect of the nonglucocorticoid 21-aminosteroid U74006F on experimental cerebral vasospasm. Surg Neurol. 31:1989;190-194.
35. Wendel A., Fausel M., Safayhi H., Tiegs G., Otter R. A novel biologically active seleno-organic compound-II, Activity of PZ 51 in relation to glutathione peroxidase. Biochem Pharmacol. 33:1984;3241-3245.
36. Wendel A., Tiegs G. A novel biologically active seleno-organic compound-VI, Protection by Ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 35:1986;2115-2118.
37. Watanabe T., Sasaki T., Asano T., Takakura K., Sano K., Fuchinoue T., Watanabe K., Yoshimura S., Abe K. Changes in glutathione peroxidase and lipid peroxides in cerebrospinal fluid and serum after subarachnoid hemorrhage, with special reference to the occurrence of cerebral vasospasm. Neurol Med Chir (Tokyo). 28:1979;645-649.
38. Zuccarello M., Marsh J.T., Schmitt G., Woodward J., Anderson D.K. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg. 71:1989;98-104.